Results for tag: "Alpha Synuclein"

Alpha Synuclein is a protein found in the brain and other parts of the nervous system. It is involved in the regulation of neurotransmitter release and is believed to play a role in the development of Parkinson's disease. As such, it has become an important target for drug development in the Central Nervous System (CNS) drugs market. Alpha Synuclein-targeting drugs are being developed to treat Parkinson's disease, as well as other neurological disorders such as dementia and multiple system atrophy. These drugs are designed to reduce the amount of Alpha Synuclein in the brain, which is believed to be a major contributor to the progression of these diseases. In addition to drug development, research is also being conducted into the role of Alpha Synuclein in other neurological disorders, such as Alzheimer's disease and amyotrophic lateral sclerosis. This research is aimed at understanding the role of Alpha Synuclein in the development of these diseases, and developing treatments that target the protein. Companies in the Alpha Synuclein market include AbbVie, Biogen, Merck, Novartis, and Pfizer. Show Less Read more